首页>Experimental dermatology>Adalimumab in conjunction with surgery in patients with moderate to severe Hidradenitis Suppurativa: Study design and baseline results from a phase 4, double-blind, randomized, placebo-controlled study
Adalimumab in conjunction with surgery in patients with moderate to severe Hidradenitis Suppurativa: Study design and baseline results from a phase 4, double-blind, randomized, placebo-controlled study